| 1 |
27671228 | Neuroprotective effects of fingolimod in mouse models of Parkinson's disease. | 2017 Jan |
1 |
| 2 |
29062606 | The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. | 2017 |
2 |
| 3 |
29082467 | Let-7d microRNA Attenuates 6-OHDA-Induced Injury by Targeting Caspase-3 in MN9D Cells. | 2017 Dec |
1 |
| 4 |
23518299 | Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. | 2013 May |
1 |
| 5 |
21846476 | Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCĪ“ in cell culture and animal models of Parkinson's disease. | 2011 Nov 1 |
3 |
| 6 |
17973977 | c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. | 2008 Feb |
1 |
| 7 |
18250162 | Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. | 2008 Apr 11 |
1 |
| 8 |
17895242 | Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. | 2007 Nov 23 |
1 |
| 9 |
17045926 | A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. | 2006 Nov 15 |
1 |
| 10 |
15596235 | Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice. | 2005 Jan |
2 |
| 11 |
14993216 | Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. | 2004 May 7 |
1 |
| 12 |
15352222 | 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. | 2004 Sep 1 |
1 |
| 13 |
12832530 | Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. | 2003 Jun 15 |
3 |
| 14 |
12867415 | Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease. | 2003 Sep 26 |
1 |
| 15 |
12397073 | Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. | 2002 Dec 27 |
2 |
| 16 |
12907839 | Down-regulation of Bcl-2, activation of caspases, and involvement of reactive oxygen species in 6-hydroxydopamine-induced thymocyte apoptosis. | 2002-2003 |
1 |